• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Orchid gets USFDA nod for injection, gets 6-mth exclusivity

      Posted AtBusiness-Standard.com

      Pharma firm Orchid Chemicals & Pharmaceuticals today said it has received the US drug regulator's nod for its Piperacillin and Tazobactam injection, used to treat infections caused by certain bacteria.

      "The US Food and Drug Administration has also determined that Orchid is first applicant for the product and has accordingly granted 180-days generic drug exclusivity, under applicable provisions," Orchid Chemicals said in a filing to the Bombay Stock Exchange.

      The company gets USFDA approval for its Abbreviated New Drug Application, the filing added.

      These approvals cover Orchid's generic equivalent in 2.25 g and 3.375 g and 4.5 g vial as well as 40.5 g dosage forms and strengths, it said.

      "We are not only the first generic product to be approved but also have been granted 180-days generic drug exclusivity," Orchid Chemicals & Pharmaceuticals Managing Director Raghavendra Rao said.

      The company would be launching this product in marketing and distribution partnership with Apotex in the US, the filing said.

      September 23, 2009


       

      Share this Article!

    Back to top^